Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide. [electronic resource]
Producer: 20070921Description: 613-22 p. digitalISSN:- 0312-5963
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- Administration, Oral
- Adult
- Aminopyridines -- administration & dosage
- Anti-Anxiety Agents -- administration & dosage
- Area Under Curve
- Aryl Hydrocarbon Hydroxylases -- antagonists & inhibitors
- Benzamides -- administration & dosage
- Cross-Over Studies
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Cyclopropanes -- administration & dosage
- Cytochrome P-450 CYP1A2
- Cytochrome P-450 CYP1A2 Inhibitors
- Cytochrome P-450 CYP2C19
- Female
- Fluvoxamine -- administration & dosage
- Half-Life
- Humans
- Male
- Middle Aged
- Mixed Function Oxygenases -- antagonists & inhibitors
- Phosphodiesterase Inhibitors -- administration & dosage
- Tablets
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.